Steven Z. Pavletic
Experimental Transplantation and Immunology Branch
The Center for Cancer Research
United States of America
Biography
Dr. Pavletic received his M.D. and M.S. Immunology from the University of Zagreb School of Medicine in Croatia. In 1992, he completed a clinical fellowship in bone marrow transplantation at the Fred Hutchinson Cancer Research Center and University of Washington Medical School in Seattle, WA. In 1995, he completed his internal medicine residency at the University of Nebraska Medical Center (UNMC) in Omaha, NE, and completed his hematology and oncology fellowship in June 1997. Until October 2002, Dr. Pavletic served as the director of the Allogeneic Stem Cell Transplantation Program at UNMC. In 2002, Dr. Pavletic received an appointment at the National Cancer Institute (NCI) and an adjunct appointment at the National Institute for Arthritis and Musculoskeletal and Skin Diseases at NIH. Currently, he is the head of the Graft-versus-Host and Autoimmunity Section in the Experimental Transplantation and Immunology Branch. In October 2006, Dr. Pavletic received the NCI Director's award for his achievements in developing national and international consensus guidelines for clinical trials in chronic GVHD. He led two NIH chronic GVHD consensus conferences in 2005 and 2014. He is also an adjunct professor at Georgetown University Lombardi Cancer Center.
Research Interest
Immunology
Publications
-
Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD. Im A, Mitchell SA, Steinberg SM, Curtis L, Berger A, Baird K, Kuzmina Z, Joe G, Comis LE, Juckett M, Avila D, Baruffaldi J, Masuch L, Pirsl F, Pavletic SZ Bone Marrow Transplant. . 51(5): 705-12, 2015
-
Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice. . Curtis LM, Datiles MB 3rd, Steinberg SM, Mitchell SA, Bishop RJ, Cowen EW, Mays J, McCarty JM, Kuzmina Z, Pirsl F, Fowler DH, Gress RE, Pavletic SZ Haematologica. haematol.2015: 2015.
-
Are we making progress in GVHD prophylaxis and treatment? . Pavletic SZ, Fowler DH Hematology Am Soc Hematol Educ Program. 2012: 251-64, 2012.
